News tagged with novartis
Drug firms sign up to new tropical disease fight
Key players in the pharmaceutical industry pledged on Monday to donate 14 billion drug treatments as part of a new, global push to eradicate tropical diseases.
Jan 30, 2012 |
not rated yet |
0
Novartis drug investigated after 11 deaths
A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died.
Medicine & Health / Medications
Jan 20, 2012 |
5 / 5 (1) |
0
First detailed data of risk of using Rasilez with certain blood pressure-lowering drugs
Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications.
Medicine & Health / Medications
Jan 12, 2012 |
not rated yet |
0
FDA: Novartis recall may also affect painkillers
(AP) -- The Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain drugs and common over-the-counter medications like Excedrin and Gas-X made at a Novartis manufacturing ...
Medicine & Health / Medications
Jan 09, 2012 |
3 / 5 (1) |
1
Swiss pharma giant Novartis recalls drugs in US
Swiss pharmaceutical firm Novartis said Sunday it was recalling four different products sold over the counter in the United States over reports of a malfunction at one of its plants.
Medicine & Health / Medications
Jan 08, 2012 |
not rated yet |
0
Novel epigenetic patterns involved in cell fate regulation
(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI) publish exciting new results on the regulation of cell fate in the scientific journal Nature. They identified ...
Dec 15, 2011 |
5 / 5 (1) |
0
|
Study: Bone drug boosts breast cancer survival
(AP) -- Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: ...
Dec 09, 2011 |
not rated yet |
0
Big promise is seen in 2 new breast cancer drugs
(AP) -- Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
Dec 08, 2011 |
not rated yet |
0
Scientists identify new class of antimalarial compounds
An international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead ...
Nov 17, 2011 |
3 / 5 (2) |
2
|
FDA approves first drug for bone marrow disorder
The first drug to treat a rare disorder that causes red blood cells to build up inside bone marrow was cleared Wednesday by the Food and Drug Administration
Medicine & Health / Medications
Nov 16, 2011 |
not rated yet |
0
Novartis announces 2,000 job losses, profits up
Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.
Oct 25, 2011 |
5 / 5 (1) |
0
Novartis fights patent rejection in Indian court
(AP) -- In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis ...
Medicine & Health / Medications
Sep 06, 2011 |
5 / 5 (3) |
0
New development could increase flu vaccine supply
(Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed a new adjuvant, or com ...
Medicine & Health / Medications
Jun 02, 2011 |
5 / 5 (2) |
0
|
UNICEF discloses vaccine prices for 1st time
UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.
Medicine & Health / Medications
May 29, 2011 |
5 / 5 (3) |
1
Is a repeat flu shot needed? This fall, maybe not
(AP) -- Vaccine makers said this month they plan to make a record amount of flu vaccine for this fall and winter - enough for more than half the population. It's just not clear all those people will need ...
May 27, 2011 |
not rated yet |
0
Novartis
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
For more information about Novartis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
